Marianne Uteng
InvestorManaging Director at Novartis Venture Fund
Basel, Switzerland
Writes $5M – $10M checks · typically $7.5M
About
Marianne Uteng, PhD, is a Managing Director at Novartis Venture Fund in Basel. She previously worked in Novartis Global Drug Development and its Pre-Clinical Safety Department, leading teams on safety assessments for early and late-stage programs, and supported Novartis BD&L Search & Evaluation while building collaborations with biotech companies and academia. She holds an MSc in Biochemistry from the University of Oslo and a PhD in Molecular Biology, Cell Biology & Biophysics from a joint EMBL–University of Oslo program.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- NovartisManaging Director at Novartis Venture Fundcurrent2023 — presentBasel, Switzerland
- AstronauTxMember Board of Directorscurrent2023 — present
- Tagworks PharmaceuticalsMember Board of Directorscurrent2023 — presentNetherlands
- Epsilogen LtdBoard Directorcurrent2022 — presentUnited Kingdom
- CatalYm GmbHBoard Observercurrent2022 — presentMunich, Bavaria, Germany
- CatalYm GmbHBoard Director2021 — 2022Germany
- Amphista Therapeutics LimitedBoard Observercurrent2021 — presentGreater London, England, United Kingdom
- Rappta TherapeuticsBoard Observercurrent2020 — presentHelsinki, Uusimaa, Finland
Skills & more
Venture CapitalBiomarkers16Biotechnology5Biomarker Discovery3Clinical Development3Clinical Trials3Drug Development2Drug Discovery4In Vitro3Biochemistry8Lifesciences10Molecular Biology14
+10 more
NMROncologyPeptidesPharmaceutical IndustryStructure ElucidationToxicologyCellLife SciencesLaboratoryCell BiologyFrom Marianne's professional profile.
Colleagues at Novartis Venture Fund
Aaron Nelson
Managing Director at Novartis Venture Fund
Adam Cotton
Principal at Novartis Venture Fund
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Anja König
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund
Frequently asked questions
- Who is Marianne Uteng?
- Marianne Uteng, PhD, is a Managing Director at Novartis Venture Fund in Basel. She previously worked in Novartis Global Drug Development and its Pre-Clinical Safety Department, leading teams on safety assessments for early and late-stage programs, and supported Novartis BD&L Search & Evaluation while building collaborations with biotech companies and academia. She holds an MSc in Biochemistry from the University of Oslo and a PhD in Molecular Biology, Cell Biology & Biophysics from a joint EMBL–University of Oslo program.
- Where does Marianne Uteng work?
- Marianne Uteng is Managing Director at Novartis Venture Fund.
- What does Marianne Uteng invest in?
- Marianne Uteng invests in Biotech.
- What check size does Marianne Uteng write?
- Marianne Uteng typically writes checks of $5M – $10M.
- Where did Marianne Uteng go to school?
- Marianne Uteng studied at European Molecular Biology Laboratory (EMBL) (PhD, Cell Biology & Biophysics); University of Oslo (Master's degree, Biochemistry).
Same school
Also attended University of Oslo41
Line Svinndal LorentsenInvestor at InvestinorPatrickInvestor at InvestinorTorInvestment Director at InvestinorNina MahmoudpourGeneral Counsel & Chief of Staff at Type One VenturesOle RuchManaging Partner at NordstarAndreas SlettvollVenture Partner at World Fund
.avif)
+ 35 more
